Rs 7 interim dividend, 2:1 bonus issue and strong Q2 growth

Bonus Above 1to1Corporate Actions View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹421.50

prior close

₹483.30

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-3.3% vs market

Healthcare Service Provider peers, median of 22sector-0.2%-2.2% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.5

10m

-5.4

15m

-6.6

30m

-8.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+1.0-3.3-0.2-2.2

Next day

+0.3+1.5-1.3-0.4+0.6

-1.2+1.0-2.2+0.2-1.3

-1.7+2.0-3.7-0.9-0.8

-0.4+3.1-3.4-1.1+0.8

-1.1+2.6-3.7-2.0+0.9

+1.9+2.7-0.7-1.9+3.8

15d

+9.5+1.8+7.7-3.6+13.1

+23.0+2.5+20.5-2.9+25.9

+3.2-2.9+6.0-9.9+13.0

+9.2-6.3+15.5-10.7+19.9

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Thyrocare declared an interim dividend of Rs 7 per share for 2025-26. October 24, 2025 is the record date, and payment is due within 30 days of the October 14 board meeting. The board recommended two bonus shares for every existing share, subject to shareholder and regulatory approval; the bonus record date will be set later. September-quarter consolidated revenue rose 22% year on year to Rs 216.53 crore, while net profit rose 29% to Rs 47.81 crore.

Likely market impact

Dividend, bonus plan and profit growth may support investor interest. The bonus needs approvals, and its record date is pending.